Veracyte in the news
January 23, 2024
Noninvasive Testing Key to Id’ing Lung Cancer
Clinical Lab Products (CLP)
January 8, 2024
Peninsula cancer test developer to pay $70 million upfront for Israeli company
San Francisco Business Times
November 8, 2023
Veracyte Taps Illumina to Develop Sequencing-Based IVDs as LDT Sales Continue Growth in Q3
GenomeWeb
August 30, 2023
HealthWatch: Nightingale Study for Lung Cancer Risk
CBS Local 5 Green Bay (WFVR)
August 8, 2023
Veracyte Prostate, Thyroid Cancer Tests Drive Q2 Growth as Firm Eyes Milestones for Newer Assays
GenomeWeb
May 26, 2023
Decipher Genomic Classifier Shows Prognostic Value in Intermediate-Risk Prostate Cancer
Urology Times
May 12, 2023
Veracyte Test Changes Chemotherapy Decisions in Breast Cancer
BioWorld